ETERNEVA, INC. – Trademark Portfolio

Entity Type: 03

ETERNEVA, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 6 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ETERNEVA, REMEMBER REMARKABLY, and ETERNALIZE THE REMARKABLE. The owner is based in AUSTIN, TX.

4115 FREIDRICH LANE, SUITE 150

AUSTIN, TX 78744

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ETERNEVA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (6 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does ETERNEVA, INC. have?

ETERNEVA, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does ETERNEVA, INC. file in?

ETERNEVA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 45 (Legal & Security Services). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are ETERNEVA, INC.'s most well-known trademarks?

ETERNEVA, INC.'s registered trademark portfolio includes well-known marks such as ETERNEVA, REMEMBER REMARKABLY, and ETERNALIZE THE REMARKABLE. These are among 4 currently registered trademarks in the portfolio.

What is ETERNEVA, INC.'s trademark registration success rate?

ETERNEVA, INC. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.